Chromosome 17/17q gain and unaltered profiles in high resolution array-CGH are prognostically informative in neuroblastoma. (Q46522600)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24737690%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

title

Chromosome 17/17q gain and unaltered profiles in high resolution array-CGH are prognostically informative in neuroblastoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24737690%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24737690%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Marc Zapatka

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24737690%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

author name string

Jessica Theissen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24737690%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Andre Oberthuer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24737690%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Anja Hombach

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24737690%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Ruth Volland

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24737690%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Matthias Fischer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24737690%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Ruediger Spitz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24737690%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Benedikt Brors

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24737690%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Monika Ortmann

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24737690%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Thorsten Simon

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24737690%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Barbara Hero

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24737690%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Frank Berthold

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24737690%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

publication date

15 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24737690%20AND%20SRC:MED&resulttype=core&format=json

Genes, Chromosomes and Cancer

14 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24737690%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24737690%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24737690%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

page(s)

639-649

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24737690%20AND%20SRC:MED&resulttype=core&format=json

Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2(SSTR2) gene at 17q24.

14 March 2020

cites work

1 reference

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee

21 January 2018

1 reference

Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification

21 January 2018

1 reference

Chromosome 1p and 11q deletions and outcome in neuroblastoma

21 January 2018

1 reference

Long-term results and risk profiles of patients in five consecutive trials (1979-1997) with stage 4 neuroblastoma over 1 year of age.

21 January 2018

1 reference

Increased WSB1 copy number correlates with its over-expression which associates with increased survival in neuroblastoma

21 January 2018

1 reference

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report

21 January 2018

1 reference

Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature

21 January 2018

1 reference

Prognostic significance of DNA di-tetraploidy in neuroblastoma

21 January 2018

1 reference

Molecular cytogenetic delineation of 17q translocation breakpoints in neuroblastoma cell lines.

21 January 2018

1 reference

Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma

21 January 2018

1 reference

Chromosome 17q12 variants contribute to risk of early-onset prostate cancer

21 January 2018

1 reference

MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma

21 January 2018

1 reference

The biologic basis for neuroblastoma heterogeneity and risk stratification

21 January 2018

1 reference

Prognostic impact of gene expression-based classification for neuroblastoma.

21 January 2018

1 reference

Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas.

21 January 2018

1 reference

Variety and complexity of chromosome 17 translocations in neuroblastoma

21 January 2018

1 reference

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).

21 January 2018

1 reference

AceView: a comprehensive cDNA-supported gene and transcripts annotation

21 January 2018

1 reference

Molecularly guided therapy of neuroblastoma: a review of different approaches

21 January 2018

1 reference

Localization of the 17q breakpoint of a constitutional 1;17 translocation in a patient with neuroblastoma within a 25-kb segment located between the ACCN1 and TLK2 genes and near the distal breakpoints of two microdeletions in neurofibromatosis type

21 January 2018

1 reference

Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma

21 January 2018

1 reference

Identification of 2 putative critical segments of 17q gain in neuroblastoma through integrative genomics

21 January 2018

1 reference

Genetic parameters of neuroblastomas

21 January 2018

1 reference

Customized Oligonucleotide Microarray Gene Expression–Based Classification of Neuroblastoma Patients Outperforms Current Clinical Risk Stratification

21 January 2018

1 reference

Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

21 January 2018

1 reference

Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma

21 January 2018

1 reference

7 January 2021

Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma

1 reference

7 January 2021

Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome

1 reference

7 January 2021

Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma

1 reference

7 January 2021

Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors

1 reference

7 January 2021

Novel mechanisms of gene disruption at the medulloblastoma isodicentric 17p11 breakpoint

1 reference

7 January 2021

Additional copies of a 25 Mb chromosomal region originating from 17q23.1-17qter are present in 90% of high-grade neuroblastomas

1 reference

7 January 2021

Risk estimation in localized unresectable single copy MYCN neuroblastoma by the status of chromosomes 1p and 11q

1 reference

7 January 2021

Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma

1 reference

7 January 2021

Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.22174

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24737690%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference